Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -15.51M
March 31, 2026 -84.00M
December 31, 2025 -22.41M
September 30, 2025 -767.50M
June 30, 2025 -30.49M
March 31, 2025 -28.79M
December 31, 2024 -23.09M
September 30, 2024 -21.23M
June 30, 2024 -30.23M
March 31, 2024 -24.81M
December 31, 2023 -563.53M
September 30, 2023 -28.02M
June 30, 2023 -7.498M
March 31, 2023 -22.18M
December 31, 2022 -200.92M
September 30, 2022 -12.84M
June 30, 2022 -31.92M
March 31, 2022 -12.94M
December 31, 2021 -11.19M
September 30, 2021 199.33M
June 30, 2021 -11.01M
March 31, 2021 -21.12M
December 31, 2020 -519.15M
September 30, 2020 -24.49M
June 30, 2020 -10.24M
Date Value
March 31, 2020 -284.64M
December 31, 2019 -0.078M
September 30, 2019 -26.12M
June 30, 2019 -24.91M
March 31, 2019 -19.92M
December 31, 2018 -118.09M
September 30, 2018 -17.85M
June 30, 2018 -41.02M
March 31, 2018 -19.43M
December 31, 2017 -774.50M
September 30, 2017 -34.40M
June 30, 2017 -41.87M
March 31, 2017 -982.09M
December 31, 2016 -16.81M
September 30, 2016 -30.72M
June 30, 2016 -12.10M
March 31, 2016 -6.571M
December 31, 2015 -46.24M
September 30, 2015 -39.73M
June 30, 2015 -47.06M
March 31, 2015 -21.82M
December 31, 2014 -36.59M
September 30, 2014 -16.24M
June 30, 2014 -15.82M
March 31, 2014 -39.49M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Globus Medical, Inc. -129.05M
Penumbra, Inc. -91.09M
Becton, Dickinson & Co. -228.00M
Boston Scientific Corp. -1.956B
DexCom, Inc. 329.80M